Mid-Cities Nephrology Associates Pa is categorized under Nephrologists in Irving, TX and active since 1981.
Mid-Cities Nephrology Associates Pa was established in 1981, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Nephrologists business, which does work in the B2C market, and is classified as a Nephrologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Geoffery Walker at the company’s single location by writing to 1625 North Story Road # 140, Irving, Texas TX 75061 or by phoning (972) 871-8282. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mid-Cities Nephrology Associates Pa |
| Contact Person: | Dr Geoffery Walker |
| Address: | 1625 North Story Road # 140, Irving, Texas 75061 |
| Phone Number: | (972) 871-8282 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Nephrologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Mid-Cities Nephrology Associates Pa was started in 1981 to provide professional Nephrologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Dr Geoffery Walker for inquiries that concern Mid-Cities Nephrology Associates Pa by calling the company number (972) 871-8282, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid-Cities Nephrology Associates Pa can be found at the coordinates as well as the street address 1625 North Story Road # 140 in Irving, Texas 75061.
For its online presence, you may visit Mid-Cities Nephrology Associates Pa’s website at and engage with its social media outlets through on Twitter and on Facebook.